GOFINTECH QUANT (00290) Issues Positive Profit Alert, Expects Interim Net Profit Attributable to Owners of the Company to Increase to Approximately HK$240 million-HK$320 million
GOFINTECH QUANT (00290) announced that the Group is expected to record net profit attributable to owners of the Company of approximately HK$240 million to HK$320 million for the six months ended September 30, 2026, compared with net profit attributable to owners of the Company of approximately HK$207 million for the corresponding period in 2025. The increase in profit was primarily due to (i) share of profits of associates; (ii) net gains on investments at fair value through profit or loss recognized during the period; and (iii) an increase in operating profit generated from the Group's principal businesses (including the Group's securities brokerage and margin financing business).
GOFINTECH QUANT (00290) announced that the Group is expected to record net profit attributable to owners of the Company of approximately HK$240 million to HK$320 million for the six months ended September 30, 2026, compared with net profit attributable to owners of the Company of approximately HK$207 million for the corresponding period in 2025. The increase in profit was primarily attributable to (i) share of profits of associates; (ii) net investment gains recognized in profit or loss at fair value during the period; and (iii) an increase in operating profit generated from the Group's principal businesses, including, among others, the Group's securities brokerage and margin financing business.
Related Articles

YUM CHINA (09987) repurchased 35,600 shares on November 16 for approximately HK$14.1806 million.

GLOBAL BIO-CHEM (00809) intends to sell all equity interests in Changchun Dacheng Bio-Technology through public tender.

NIKE, Inc. Class B (NKE.US) lays out a clear growth path for the next five years: targeting US$5 billion in incremental revenue by fiscal 2031.
YUM CHINA (09987) repurchased 35,600 shares on November 16 for approximately HK$14.1806 million.

GLOBAL BIO-CHEM (00809) intends to sell all equity interests in Changchun Dacheng Bio-Technology through public tender.

NIKE, Inc. Class B (NKE.US) lays out a clear growth path for the next five years: targeting US$5 billion in incremental revenue by fiscal 2031.






